|Bid||13.92 x 1400|
|Ask||14.16 x 1300|
|Day's Range||14.12 - 14.83|
|52 Week Range||4.96 - 19.32|
|Beta (5Y Monthly)||1.25|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
NEW YORK, November 10, 2021--Iveric announced that Glenn P. Sblendorio, CEO, and Pravin Dugel, M.D., President, will participate in the Stifel 2021 Virtual Healthcare Conference.
NEW YORK, November 09, 2021--Iveric Bio announced financial and operating results for the quarter ended September 30, 2021 and provided a general business update.
NEW YORK, November 03, 2021--Iveric Bio announced that the Company will participate in a fireside chat at the Credit Suisse 30th Annual Virtual Healthcare Conference on Nov. 9.